T cell responses against SARS-CoV-2 and its Omicron variant in a patient with B cell lymphoma after multiple doses of a COVID-19 mRNA vaccine.
J Immunother Cancer
; 10(7)2022 07.
Article
in En
| MEDLINE
| ID: mdl-35851312
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, B-Cell
/
COVID-19 Vaccines
/
COVID-19
Limits:
Humans
Language:
En
Journal:
J Immunother Cancer
Year:
2022
Type:
Article
Affiliation country:
United States